Search

Your search keyword '"Deimling, Andreas"' showing total 3,485 results

Search Constraints

Start Over You searched for: Author "Deimling, Andreas" Remove constraint Author: "Deimling, Andreas"
3,485 results on '"Deimling, Andreas"'

Search Results

1. Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines

3. Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07)

4. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas

5. EpiDiP/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnostics

6. Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma

9. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation

13. Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042

14. Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics

15. Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

16. Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification

17. Spindle Cell Lesions with Oncogenic EGFR Kinase Domain Aberrations: Expanding the Spectrum of Protein Kinase–Related Mesenchymal Tumors

18. A H3K27M-targeted vaccine in adults with diffuse midline glioma

19. Wnt/β-Catenin–Activated Nonpilomatrical Carcinoma of the Skin: A Case Series

20. Intracranial mesenchymal tumors with FET‐CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas

21. Concurrent gliomas in patients with multiple sclerosis

24. INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas

26. Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature

28. Genomic characterization of DICER1-associated neoplasms uncovers molecular classes

30. Oligosarcomas, IDH-mutant are distinct and aggressive

32. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions

33. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

34. Genetic and epigenetic characterization of posterior pituitary tumors

35. Subgroup and subtype-specific outcomes in adult medulloblastoma.

36. The Epigenetic Landscape of Meningiomas

37. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

39. Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology

40. Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification

41. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1

42. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1

43. Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma

44. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

45. A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic Profile

46. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)

47. A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.

48. Author Correction: Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology

49. Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts

50. Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinases

Catalog

Books, media, physical & digital resources